Vident Advisory, LLC

SEC CIK: 0001744347
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

TLX holding history

Telix Pharmaceuticals Ltd in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TLX overview All 13F holders of TLX Full Q2 2026 holdings

Shares (Q2 2026): 11,955
Value: $137.8K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of TLX by Vident Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	11,955	$137.8K	<0.1%	−4,698−28.2%	Reduced	Holders
Q1 2026	16,653	$159.4K	<0.1%	−10,596−38.9%	Reduced	Holders
Q4 2025	27,249	$204.1K	<0.1%	+27,249	New	Holders